ArticleLeukemia2026

Daratumumab plus bortezomib, lenalidomide, and dexamethasone in transplant-deferred newly diagnosed multiple myeloma: Frailty subgroup analysis of CEPHEUS.

Sonja Zweegman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.